Pacira Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Hi. Good morning. So my name is [Balaji] from Barclays, and we have with us today, Richard -- Charles Reinhart, the CFO of Pacira; and also management team from Pacira, including Richard Scranton, Chief Scientific Officer; and Susan Mesco, Investor Relations. Charlie?
Thank you. Good morning, everyone, and thanks to Barclays for giving us the opportunity to present this morning.
All right. Get the slides, there we go. So before we start, I have to do a quick reminder that this morning's discussion will include forward-looking statements, which may or may not reflect the actual results. And so therefore, I suggest people take a look at our 10-K to get a better understanding of the risks related to our business.
So everybody is familiar with the impact of the opioid epidemic, and the ravaging effects it's had in America. It's our company mission to provide an opioid alternative to as many patients as we can. We believe that we will be successful in this mission by developing
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
